Bullfrog AI (BFRG) Competitors

$2.91
+0.02 (+0.69%)
(As of 03:02 PM ET)

BFRG vs. TXMD, GDTC, CPIX, LSTA, RNXT, SYBX, BNTC, SLGL, MEIP, and TCRT

Should you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include TherapeuticsMD (TXMD), CytoMed Therapeutics (GDTC), Cumberland Pharmaceuticals (CPIX), Lisata Therapeutics (LSTA), RenovoRx (RNXT), Synlogic (SYBX), Benitec Biopharma (BNTC), Sol-Gel Technologies (SLGL), MEI Pharma (MEIP), and Alaunos Therapeutics (TCRT). These companies are all part of the "pharmaceutical preparations" industry.

Bullfrog AI vs.

Bullfrog AI (NASDAQ:BFRG) and TherapeuticsMD (NASDAQ:TXMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations.

TherapeuticsMD received 386 more outperform votes than Bullfrog AI when rated by MarketBeat users.

CompanyUnderperformOutperform
Bullfrog AIN/AN/A
TherapeuticsMDOutperform Votes
386
62.46%
Underperform Votes
232
37.54%

In the previous week, TherapeuticsMD had 2 more articles in the media than Bullfrog AI. MarketBeat recorded 6 mentions for TherapeuticsMD and 4 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 1.45 beat TherapeuticsMD's score of 0.80 indicating that Bullfrog AI is being referred to more favorably in the media.

Company Overall Sentiment
Bullfrog AI Positive
TherapeuticsMD Positive

Bullfrog AI has higher earnings, but lower revenue than TherapeuticsMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bullfrog AI$60K378.11-$5.36M-$0.88-3.28
TherapeuticsMD$1.30M18.00-$10.28MN/AN/A

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 30.7% of TherapeuticsMD shares are held by institutional investors. 1.2% of TherapeuticsMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
TherapeuticsMD
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

TherapeuticsMD's return on equity of -21.00% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Bullfrog AIN/A -158.09% -136.58%
TherapeuticsMD N/A -21.00%-12.61%

Bullfrog AI has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, TherapeuticsMD has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

Summary

TherapeuticsMD beats Bullfrog AI on 8 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRG vs. The Competition

MetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$22.69M$6.50B$4.81B$7.76B
Dividend YieldN/A2.76%38.74%3.93%
P/E Ratio-3.288.92108.8313.77
Price / Sales378.11253.082,366.5377.81
Price / CashN/A20.3631.9828.46
Price / Book6.725.834.894.56
Net Income-$5.36M$135.49M$100.28M$215.14M
7 Day Performance-4.30%1.68%114.45%0.45%
1 Month Performance-5.86%0.64%117.63%2.35%
1 Year Performance-39.03%1.30%130.08%10.69%

Bullfrog AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TXMD
TherapeuticsMD
0 of 5 stars
$1.96
flat
N/A-53.8%$22.60M$1.30M0.001Analyst Forecast
News Coverage
GDTC
CytoMed Therapeutics
1.22 of 5 stars
$2.05
-4.7%
$5.00
+143.9%
-27.3%$22.43MN/A0.00N/AShort Interest ↑
Gap Down
CPIX
Cumberland Pharmaceuticals
0 of 5 stars
$1.58
+3.3%
N/A-6.7%$22.40M$39.55M-3.5991Analyst Forecast
Short Interest ↑
Gap Up
LSTA
Lisata Therapeutics
3.5965 of 5 stars
$2.75
-0.7%
$15.00
+445.5%
-10.6%$23.01MN/A-1.0725Short Interest ↓
Gap Down
RNXT
RenovoRx
2.0813 of 5 stars
$1.30
+3.2%
$8.50
+553.8%
-27.9%$21.93MN/A-1.298Upcoming Earnings
Short Interest ↓
Gap Up
SYBX
Synlogic
3.4198 of 5 stars
$1.84
flat
$65.00
+3,432.6%
-78.5%$21.40M$3.37M-0.176Short Interest ↓
BNTC
Benitec Biopharma
1.5879 of 5 stars
$8.15
-2.0%
$16.00
+96.3%
+156.4%$21.11M$80,000.000.0016Upcoming Earnings
Short Interest ↑
Gap Down
SLGL
Sol-Gel Technologies
3.7943 of 5 stars
$0.75
-8.5%
$8.00
+966.7%
-79.3%$20.90M$1.55M-0.7436Short Interest ↓
MEIP
MEI Pharma
4.299 of 5 stars
$3.13
-2.2%
$7.00
+123.6%
-56.9%$20.85M$48.82M1.0546
TCRT
Alaunos Therapeutics
0 of 5 stars
$1.30
-1.5%
N/A-85.5%$20.81MN/A-0.541Upcoming Earnings
Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:BFRG) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners